LIVE · 2026-09-03 05:20 UTC

ALNY Alnylam Pharmaceuticals, Inc.

Pharmaceutical Preparations · Nasdaq · SEC EDGAR official

Market Value*

$42.63B

Revenue (FY)

$3.71B 2025-12-31

Net Income (FY)

$313.75M

P/E (float-based)

135.9

Revenue History

Net Income History

*Market value = public float disclosed in latest 10-K filing · CIK 1178670 · SEC filings · revenue ranking · home